| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 临床研究服务(元) | 243,686,889.98 | 109,967,666.56 | 188,119,170.78 | 78,738,830.39 |
| 药学研究服务(元) | 60,452,446.00 | 28,093,708.42 | 50,020,022.40 | 21,125,504.22 |
| 其他(元) | 37,667,196.87 | 13,181,566.86 | 8,073,091.40 | 2,083,891.15 |
| 营业成本(元) | ||||
| 临床研究服务(元) | 145,614,775.70 | 61,729,109.39 | 108,978,309.87 | 46,612,363.62 |
| 药学研究服务(元) | 21,114,901.98 | 9,212,107.50 | 16,399,710.91 | 5,982,292.01 |
| 其他(元) | 7,804,123.84 | 7,595,278.03 | 2,290,738.12 | 1,035,552.98 |
| 毛利(元) | ||||
| 临床研究服务(元) | 98,072,114.28 | 48,238,557.17 | 79,140,860.91 | 32,126,466.77 |
| 药学研究服务(元) | 39,337,544.02 | 18,881,600.92 | 33,620,311.49 | 15,143,212.21 |
| 其他(元) | 29,863,073.03 | 5,586,288.83 | 5,782,353.28 | 1,048,338.17 |
| 毛利率(%) | ||||
| 临床研究服务(%) | 40.25 | 43.87 | 42.07 | 40.80 |
| 药学研究服务(%) | 65.07 | 67.21 | 67.21 | 71.68 |
| 其他(%) | 79.28 | 42.38 | 71.63 | 50.31 |
| 收入构成(%) | ||||
| 临床研究服务(%) | 71.29 | 72.71 | 76.41 | 77.23 |
| 药学研究服务(%) | 17.69 | 18.58 | 20.32 | 20.72 |
| 其他(%) | 11.02 | 8.72 | 3.28 | 2.04 |
| 毛利构成(%) | ||||
| 临床研究服务(%) | 58.63 | 66.35 | 66.76 | 66.49 |
| 药学研究服务(%) | 23.52 | 25.97 | 28.36 | 31.34 |
| 其他(%) | 17.85 | 7.68 | 4.88 | 2.17 |